loading page

Application and progress of CRISPR Cas9 gene editing in B-cell lymphoma
  • +1
  • Ying Jin,
  • Haiyi Wu,
  • Jianzhao Liu,
  • Guo Song
Ying Jin
Nantong University Medical School
Author Profile
Haiyi Wu
Nantong University
Author Profile
Jianzhao Liu
Dalian Medical University
Author Profile
Guo Song
Affiliated Hospital of Nantong University

Corresponding Author:[email protected]

Author Profile


In latest years, with the gradual perception of CRISPR Cas9 technology, coupled with the many advantages of the CRISPR Cas9 system, ease of development, simplicity of use, and low material prices, its mediated gene modifying has been higher used in diagnosing and treating genetic ailments and enhancing patients' prognosis. Moreover, CRISPR Cas9 gene screening library is another hot issue which can be used to discover pathogenic genes, pick drug intervention sites, and analyze drug resistance mechanisms. Rapidly emerging gene editing technology has a huge market and is expected to cure B-cell lymphoma. This article reviews the application and progress of CRISPR Cas9 gene editing in B-cell lymphoma for further study.
05 Apr 2023Submitted to Cancer Reports
06 Apr 2023Assigned to Editor
06 Apr 2023Submission Checks Completed
06 Apr 2023Review(s) Completed, Editorial Evaluation Pending
06 Apr 2023Reviewer(s) Assigned
25 Apr 2023Editorial Decision: Revise Major